Roche Banks on New Drug Data to Defend Cancer Business
5/16/2013
More...
|
Eli Lilly and Company to Take $30 Million Charge After Cancer Drug Fails Phase 3 Trial
5/15/2013
More...
|
ZIOPHARM Oncology, Inc. Cancer Drug Fails in Late-Stage Trial; Shares Plunge
3/27/2013
More...
|
Sun Pharmaceutical Industries Ltd Receives U.S. Nod for Cancer Drug "Doxil"
2/7/2013
More...
|
Genentech's Cancer-Fighting T-DM1 Leads FDA Class of 2013
1/2/2013
More...
|
Merck & Co., Inc., Roche and Sanofi (France) to Test Drug That Aims to Make Cancer Self-Destruct
1/1/2013
More...
|
AEterna Zentaris Says FDA Supports Phase 3 Trials of Cancer Treatment
1/1/2013
More...
|
Celgene's Pomalidomide Helps in Myeloma After Others Fail
12/12/2012
More...
|
Strides Arcolab Limited Inks Pact With Eli Lilly and Company for Cancer Drugs
12/5/2012
More...
|
Cipla Ltd. Slashes Cancer Drug Prices by Up to 64 Pct
11/8/2012
More...
|
Big Pharmas Such as Roche. Eli Lilly and Company Crunch the Numbers to Boost Odds Against Cancer
11/2/2012
More...
|
Ensemble Therapeutics Corporation, Boehringer Ingelheim Corporation Ink $186 Milliion Macrocycle Drug Pact
11/1/2012
More...
|
Menarini, Oxford BioTherapeutics Ink $1 Billion Cancer Pact; Partnership Will Develop Five Antibody-Based Anticancer Drugs
10/29/2012
More...
|
Novartis AG Cannibalizes Gleevec to Boost New Cancer Drug
10/29/2012
More...
|
Abbott Laboratories, Seattle Genetics, Inc. Sign Cancer Pact Worth $245 Million
10/23/2012
More...
|